hydralazine has been researched along with Substance Withdrawal Syndrome in 4 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sudden withdrawal of oral therapy with hydralazine for reduction of afterload in a patient precipitated severe congestive heart failure." | 7.66 | Precipitation of heart failure following sudden withdrawal of hydralazine. ( Black, JR; Mehta, J, 1979) |
| " It has also been used intravenously in phaeochromocytoma, tetanus, clonidine withdrawal, and as an adjunct to halothane to produce hypotensive anaesthesia." | 4.76 | Combined alpha- and beta-receptor inhibition in the treatment of hypertension. ( Prichard, BN, 1984) |
| " To test if these structural changes occur in the absence of raised blood pressure, hydralazine was administered to spontaneously hypertensive rats and normotensive controls prior to and during pregnancy (100 ml/l drinking water), and to the newborn males up to 21 weeks of age (16." | 3.67 | Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension. ( Forrest, JB; Lee, RM; Smeda, JS, 1988) |
| "Sudden withdrawal of oral therapy with hydralazine for reduction of afterload in a patient precipitated severe congestive heart failure." | 3.66 | Precipitation of heart failure following sudden withdrawal of hydralazine. ( Black, JR; Mehta, J, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prichard, BN | 1 |
| Black, JR | 1 |
| Mehta, J | 1 |
| Penhall, RK | 1 |
| Frewin, DB | 1 |
| Smeda, JS | 1 |
| Lee, RM | 1 |
| Forrest, JB | 1 |
1 review available for hydralazine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihyp | 1984 |
3 other studies available for hydralazine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Precipitation of heart failure following sudden withdrawal of hydralazine.
Topics: Administration, Oral; Aged; Aortic Valve Insufficiency; Digoxin; Furosemide; Heart Failure; Hemodyna | 1979 |
Sinus tachycardis in a hypertensive patient: drug withdrawal phenomenon?
Topics: Arrhythmia, Sinus; Female; Humans; Hydralazine; Hypertension; Middle Aged; Propranolol; Substance Wi | 1977 |
Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension.
Topics: Animals; Animals, Newborn; Blood Pressure; Blood Vessels; Female; Hydralazine; Muscle, Smooth, Vascu | 1988 |